BD publishes latest financial update

BD has published its financial details for the fourth fiscal quarter and the full year to date, reporting revenues of $1.898 billion (1.147 billion pounds) for the three months ended September 30th 2009.

This figure represents an increase of five per cent on the same time last year.

The firm also reported revenues of $7.161 billion for the full fiscal year ended September 30th, a rise of one per cent compared to the same time in 2008.

Additionally, diluted earnings per share from continuing operations stood at $1.25 for the fourth quarter of 2009, an increase of 13 per cent from continuing operations of $1.11 for the fourth quarter of last year.

Edward Ludwig, chairman and chief executive officer of the organisation, commented: “The achievement of solid fourth-quarter performance, in particular BD Medical and BD Diagnostics, marks the conclusion of another successful year for BD.”

Last month, BD announced that it had acquired HandyLab – a company that specialises in the development and manufacturing of molecular diagnostic assays and automation platforms.